Chromosome 10, frequently lost in human melanoma, encodes multiple tumor-suppressive functions

Cancer Research

Volumn 74, Issue 6, 2014, Pages 1814-1821

  Kwong, Lawrence N ^a   Chin, Lynda ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLIM1 GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CHROMOSOME 10; CHROMOSOME 11Q; CHROMOSOME 21; CHROMOSOME 6Q; CHROMOSOME LOSS; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOMA; MOUSE; MULTIPLE CANCER; NONHUMAN; PRIORITY JOURNAL; PTEN GENE; RNA INTERFERENCE; TUMOR GROWTH; TUMOR INVASION; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE, TUMOR; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 10; DNA COPY NUMBER VARIATIONS; GENE KNOCKDOWN TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; LIM DOMAIN PROTEINS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE, NUDE; MICROFILAMENT PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RNA, SMALL INTERFERING; TRANSCRIPTOME;

EID: 84896536169     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-1446     Document Type: Article

References (29)

1. Chin L, Hahn WC, Getz G, Meyerson M. Making sense of cancer genomic data. Genes Dev 2011;25:534-55.
2. Yates LR, Campbell PJ. Evolution of the cancer genome. Nat Rev Genet 2012;13:795-806.
3. Ghosh P, Chin L. Genetics and genomics of melanoma. Expert Rev Dermatol 2009;4:131.
4. Shi H, Moriceau G, Kong X, Lee MK, Lee H, Koya RC, et al. Melanoma whole-exome sequencing identifies V600EB-RAF amplification-mediated acquired B-RAF inhibitor resistance. Nat Commun 2012;3:724.
5. Vízkeleti L, Ecsedi S, Rakosy Z, Orosz A, Lazar V, Emri G, et al. The role of CCND1 alterations during the progression of cutaneous malignant melanoma. Tumor Biol 2012;33:2189-99.
6. Kabbarah O, Nogueira C, Feng B, Nazarian RM, Bosenberg M, Wu M, et al. Integrative genome comparison of primary and metastatic melanomas. PLoS ONE 2010;5:e10770.
7. Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, Marmion JM, et al. Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 2008;68:664-73. (Pubitemid 351206741)
8. Solimini NL, Xu Q, Mermel CH, Liang AC, Schlabach MR, Luo J, et al. Recurrent hemizygous deletions in cancers may optimize proliferative potential. Science 2012;337:104-9.
9. Xue W, Kitzing T, Roessler S, Zuber J, Krasnitz A, Schultz N, et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc Natl Acad Sci 2012;109:8212-7.
10. Cowan J, Francke U. Cytogenetic analysis in melanoma and nevi. In: Nathanson L, editor. Melanoma Research: Genetics, Growth Factors, Metastases, and Antigens: Springer US; 1991. p. 3-16.
11. Guldberg P, thor Straten P, Birck A, Ahrenkiel V, Kirkin AF, Zeuthen J. Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Res 1997;57: 3660-3. (Pubitemid 27381203)
12. Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, et al. In vitro loss of heterozygosity targets the PTEN/ MMAC1 gene in melanoma. Proc Natl Acad Sci 1998;95:9418-23. (Pubitemid 28506246)
13. McClintick J, Edenberg H. Effects of filtering byPresent call on analysis of microarray experiments. BMC Bioinformatics 2006;7:49.
14. Talantov D, Mazumder A, Yu JX, Briggs T, Jiang Y, Backus J, et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res 2005;11:7234-42. (Pubitemid 41507680)
15. Riker A, Enkemann S, Fodstad O, Liu S, Ren S, Morris C, et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis. BMC Med Genomics 2008;1:13.
16. Kwong LN, Costello JC, Liu H, Jiang S, Helms TL, Langsdorf AE, et al. Oncogenic NRAS signaling differentially regulates survival and proliferation in melanoma. Nat Med 2012;18:1503-10.
17. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, Feng B, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 2006;125:1269-81. (Pubitemid 43949521)
18. Nogueira C, Kim KH, Sung H, Paraiso KHT, Dannenberg JH, Bosenberg M, et al. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene 2010;29:6222-32.
19. Muller FL, Colla S, Aquilanti E, Manzo VE, Genovese G, Lee J, et al. Passenger deletions generate therapeutic vulnerabilities in cancer. Nature 2012;488:337-42.
20. Hirsch D, Kemmerling R, Davis S, Camps J, Meltzer PS, Ried T, et al. Chromothripsis and focal copy number alterations determine poor outcome in malignant melanoma. Cancer Res 2012;73:1454-60.
21. Rakosy Z, Ecsedi S, Toth R, Vizkeleti L, Herandez-Vargas H, Lazar V, et al. Integrative genomics identifies gene signature associated with melanoma ulceration. PLoS ONE 2013;8:e54958.
22. Gobeil S, Zhu X, Doillon CJ, Green MR. A genome-wide shRNA screen identifies GAS1 as a novel melanoma metastasis suppressor gene. Genes Dev 2008;22:2932-40.
23. Tang W, Dodge M, Gundapaneni D, Michnoff C, Roth M, Lum L. A genome-wide RNAi screen for Wnt/b-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc Natl Acad Sci 2008;105:9697-702. (Pubitemid 352031363)
24. Angus-Hill ML, Elbert KM, Hidalgo J, Capecchi MR. T-cell factor 4 functions as a tumor suppressor whose disruption modulates colon cell proliferation and tumorigenesis. Proc Natl Acad Sci 2011;108: 4914-9.
25. Chen H-M, Schmeichel KL, Mian IS, Lelievre S, Petersen OW, Bissell MJ. AZU-1: a candidate breast tumor suppressor and biomarker for tumor progression. Mol Biol Cell 2000;11:1357-67. (Pubitemid 30211035)
26. Lauffart B, Gangisetty O, Still IH. Molecular cloning, genomic structure and interactions of the putative breast tumor suppressor TACC2.
27. Genomics 2003;81:192-201.
28. Takayama K, Horie-Inoue K, Suzuki T, Urano T, Ikeda K, Fujimura T, et al. TACC2 is an androgen-responsive cell cycle regulator promoting androgen-mediated and castration-resistant growth of prostate cancer. Mol Endocrinol 2012;26:748-61.
29. Uren AG, Kool J, Matentzoglu K, de Ridder J, Mattison J, van Uitert M, et al. Large-scale mutagenesis in p19ARF-And p53-deficient mice identifies cancer genes and their collaborative networks. Cell 2008; 133:727-41. (Pubitemid 351637624)